Shanrong Biotechnology Corp
Shanrong Biotechnology Corp. does not have significant operations. Previously, it was operated as a project management and executive consulting company. The company was formerly known as Defense Solutions Holding, Inc. and changed its name to Shanrong Biotechnology Corp. in September 2017. Shanrong Biotechnology Corp. is based in Torrance, California.
Market Cap & Net Worth: Shanrong Biotechnology Corp (SRBT)
Shanrong Biotechnology Corp (PINK:SRBT) has a market capitalization of $400.19 Million ($400.19 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #41166 globally and #13380 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shanrong Biotechnology Corp's stock price $0.40 by its total outstanding shares 1000484853 (1.00 Billion).
Shanrong Biotechnology Corp Market Cap History: 2015 to 2025
Shanrong Biotechnology Corp's market capitalization history from 2015 to 2025. Data shows growth from $120.06 Million to $400.19 Million (11.78% CAGR).
Shanrong Biotechnology Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shanrong Biotechnology Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of SRBT by Market Capitalization
Companies near Shanrong Biotechnology Corp in the global market cap rankings as of March 19, 2026.
Key companies related to Shanrong Biotechnology Corp by market ranking:
- CLUS (PINK:CLUS): Ranked #1968 globally with a market cap of $8.00 Billion USD.
- Cartesian Growth Corporation II Warrant (NASDAQ:RENEW): Ranked #8546 globally with a market cap of $736.93 Million USD.
- Nh Special Purpose Acquisition 14 Co. Ltd (KQ:319400): Ranked #8994 globally with a market cap of $660.01 Million USD ( ₩966.39 Billion KRW).
- EQV Ventures Acquisition Corp. II (NYSE:EVAC): Ranked #10613 globally with a market cap of $465.51 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1968 | CLUS | PINK:CLUS | $8.00 Billion | $200.00 |
| #8546 | Cartesian Growth Corporation II Warrant | NASDAQ:RENEW | $736.93 Million | $138.87 |
| #8994 | Nh Special Purpose Acquisition 14 Co. Ltd | KQ:319400 | $660.01 Million | ₩30450.00 |
| #10613 | EQV Ventures Acquisition Corp. II | NYSE:EVAC | $465.51 Million | $10.07 |
Shanrong Biotechnology Corp Historical Marketcap From 2015 to 2025
Between 2015 and today, Shanrong Biotechnology Corp's market cap moved from $120.06 Million to $ 400.19 Million, with a yearly change of 11.78%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $400.19 Million | +2.56% |
| 2024 | $390.19 Million | -2.26% |
| 2023 | $399.19 Million | -46.80% |
| 2022 | $750.36 Million | +36.36% |
| 2021 | $550.27 Million | +1000.00% |
| 2020 | $50.02 Million | -72.54% |
| 2019 | $182.19 Million | -82.15% |
| 2018 | $1.02 Billion | +22.89% |
| 2017 | $830.40 Million | +137.14% |
| 2016 | $350.17 Million | +191.67% |
| 2015 | $120.06 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Shanrong Biotechnology Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $400.19 Million USD |
| MoneyControl | $400.19 Million USD |
| MarketWatch | $400.19 Million USD |
| marketcap.company | $400.19 Million USD |
| Reuters | $400.19 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.